With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, presented new data on its Optimer therapeutic delivery vehicle for ...

The single-stranded DNA molecules developed by researchers using the SELEX technology could transform blood testing for Alzheimer's biomarkers. These synthetic aptamers target neurofilament light ...

Precision medicine is of substantial significance in contemporary medicine as it enables targeted interventions for a variety of diseases with a relatively low probability of side - effects. Nucleic ...

Aptamers, nucleic acids capable of selectively binding to viruses, proteins, ions, small molecules, and various other targets, are garnering attention in drug development as potential antibody ...